-transparent.png){kind=logo}
Veratramine produces a characteristic excitatory action on the central nervous system, producing both tremor and a characteristic "struggling" behavior. This behavioral excitation is accompanied by changes in serotonin content in hypothalamus. The central serotonin agonist methysergide in doses of 5--15 mg per kg produces a dose-dependent inhibition of veratramine's action, while parachlorophenylalanine has no effect. These results are consistent with a serotonin agonist mechanism to explain veratramine's action.
Related Publications
K Izumi, and
R F Butterworth, and
G Tunnicliff, and
M Gonce, and
A Barbeau
December 1966,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
K Izumi, and
R F Butterworth, and
G Tunnicliff, and
M Gonce, and
A Barbeau
January 1958,
Archivos del Instituto de Cardiologia de Mexico,
K Izumi, and
R F Butterworth, and
G Tunnicliff, and
M Gonce, and
A Barbeau
April 1949,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
K Izumi, and
R F Butterworth, and
G Tunnicliff, and
M Gonce, and
A Barbeau
January 1968,
Advances in pharmacology,
K Izumi, and
R F Butterworth, and
G Tunnicliff, and
M Gonce, and
A Barbeau
March 1980,
Revista espanola de fisiologia,
K Izumi, and
R F Butterworth, and
G Tunnicliff, and
M Gonce, and
A Barbeau
August 1955,
Science (New York, N.Y.),
K Izumi, and
R F Butterworth, and
G Tunnicliff, and
M Gonce, and
A Barbeau
October 1951,
The Journal of pharmacology and experimental therapeutics,
K Izumi, and
R F Butterworth, and
G Tunnicliff, and
M Gonce, and
A Barbeau
July 1982,
Pharmacopsychiatria,
K Izumi, and
R F Butterworth, and
G Tunnicliff, and
M Gonce, and
A Barbeau
October 1961,
Archives internationales de pharmacodynamie et de therapie,
K Izumi, and
R F Butterworth, and
G Tunnicliff, and
M Gonce, and
A Barbeau
December 1999,
Cephalalgia : an international journal of headache,
